fashion -WSS

fashion

author：hotspot 2025-10-02 21:05:33 - browse：51

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： U.K. researchers warn about biases in medical devices, algorithms

WSS

Nurses recount patients attacks

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Argenx readies a blockbuster opportunity with drug for autoimmune disease

7 of the most gruesome medical devices in history

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

CDC backtracks, saying fully vaccinated people can go maskless indoors

focus

fashion

entertainment

Walensky prepares to leave CDC — and Congress — behind

U.K. researchers warn about biases in medical devices, algorithms

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why an extreme heat and wildfire smoke combination can be so dangerous

Supreme Court strikes down use of affirmative action

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Duchenne breakthrough therapy leaves behind pioneering families

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Malaria cases in Florida and Texas: Here’s what you need to know

CVS Caremark has created a new ploy: the drug ‘rebate credit’

focus

Virtual Event: March of the Biosimilars

Orchard's therapy for neuron disease in children wins FDA approval

Organ transplantation is at a crossroads. Major reform is needed

U.K. researchers warn about biases in medical devices, algorithms

Creating egg and sperm cells from stem cells raises ethical issues

Court strikes down limits on filming of police in Arizona

knowledge

Wikipedia

explore

focus